Am J Gastroenterol

1. KURT G, Troelsen FS, Veres K, Sorensen HT, et al
   Risk of venous thromboembolism following colorectal cancer surgery in patients with and without inflammatory bowel disease.
   Am J Gastroenterol. 2025 Sep 3. doi: 10.14309/ajg.0000000000003761.
   

   >> Share

   
   

   
   Clin Gastroenterol Hepatol

2. HANZEL J, Vuyyuru SK, Bressler B, Samaan MA, et al
   Reliability and Responsiveness of Endoscopic Indices for Assessing Crohn's Disease Postoperative Recurrence in the PREVENT trial.
   Clin Gastroenterol Hepatol. 2025 Sep 2:S1542-3565(25)00741.
   

   >> Share

   
   

   
   Clin Res Hepatol Gastroenterol

3. DUQUEROIS AS, Martinez-Vinson C, Loppinet T, Restier L, et al
   A series of pediatric patients with inflammatory bowel disease switching from intravenous to subcutaneous infliximab maintenance therapy.
   Clin Res Hepatol Gastroenterol. 2025;49:102680.
   

   >> Share

   
   

   
   Dig Dis Sci

4. ISHIDA N, Sugimoto K
   Annual Infliximab Monitoring After Treatment Optimization.
   Dig Dis Sci. 2025;70:2944-2946.
   

   >> Share

   
   
5. WANG C, Lv G, Chen E, Xue Y, et al
   Cross-Trait Cross-Genome Cross-Organ Analysis of Gastrointestinal Disorders and Depression.
   Dig Dis Sci. 2025;70:3021-3033.
   

   >> Share

   
   

   
   Eur J Gastroenterol Hepatol

6. HUANG C, Czuber-Dochan W, Norton C
   Home-based transcutaneous electrical acupuncture-point stimulation for depressive symptoms in inflammatory bowel disease: a randomized feasibility study.
   Eur J Gastroenterol Hepatol. 2025 Jul 14. doi: 10.1097/MEG.0000000000003034.
   

   >> Share

   
   
7. BRAASCH T, Siegmund B
   The role of chest X-ray in latent tuberculosis infection screening for inflammatory bowel disease patients in low-incidence countries: in response to Gatt et al. (Eur J Gastroenterol Hepatol 2025;37:728-732).
   Eur J Gastroenterol Hepatol. 2025;37:1186.
   

   >> Share

   
   
8. MANTAKA A, Apostolakis I, Domeyer PR, Sarafis P, et al
   Quality of care in inflammatory bowel disease from patient's perspective using QUOTE-IBD: a Greek multicenter prospective study.
   Eur J Gastroenterol Hepatol. 2025 Jul 14. doi: 10.1097/MEG.0000000000003031.
   

   >> Share

   
   

   
   Gastroenterol Hepatol

9. ELOSUA A, Nantes O, Chaparro M, Zabalza L, et al
   Early Advanced Therapies and Real-World Outcomes in Crohn's Disease: A Population-Based Comparison of Two Incident Cohorts in Navarra.
   Gastroenterol Hepatol. 2025 Aug 31:502540. doi: 10.1016/j.gastrohep.2025.502540.
   

   >> Share

   
   

   
   Inflamm Bowel Dis

10. D'ARCANGELO G, De Mitri D, Busato L, Bottino L, et al
    The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn's Disease.
    Inflamm Bowel Dis. 2025 Sep 5:izaf193. doi: 10.1093.
    

    >> Share

    
    
11. KLEIN S, Sivasailam B, Alizadeh M, Malter L, et al
    Clinical Research: Disparities in Outcomes for Patients With Inflammatory Bowel Disease at a Private vs Public Hospital in New York City.
    Inflamm Bowel Dis. 2025 Sep 5:izaf174. doi: 10.1093.
    

    >> Share

    
    
12. 
    Correction to: Fecal Microbial Community Profiling Allows Discrimination of Phenotype and Treatment Response in Pediatric Crohn's Disease and Ulcerative Colitis-An International Meta-Analysis.
    Inflamm Bowel Dis. 2025 Sep 4:izaf200. doi: 10.1093.
    

    >> Share

    
    
13. DAY AS, Slater R, Young RB, Wheeler RZ, et al
    Functional Profiling Demonstrates That a Sulfide-Reducing Diet Achieves Microenvironmental Targets in Ulcerative Colitis.
    Inflamm Bowel Dis. 2025 Sep 3:izaf177. doi: 10.1093.
    

    >> Share

    
    

    
    J Clin Gastroenterol

14. CHEN M, Lin Y, Wang B
    When Normal Imaging Says Enough: Rethinking the Role of Patency Capsule in Crohn's Disease.
    J Clin Gastroenterol. 2025 Sep 1. doi: 10.1097/MCG.0000000000002246.
    

    >> Share

    
    

    
    J Crohns Colitis

15. JANS DS, Depovere J, Lee HS, Abakkouy Y, et al
    Unravelling the genetic architecture of inflammatory bowel disease multiplex families with rare and common variant polygenic risk scores.
    J Crohns Colitis. 2025 Sep 5:jjaf165. doi: 10.1093.
    

    >> Share

    
    
16. NERI B, Schiavone SC, Mancone R, Fiorillo M, et al
    Clinical Outcome After Entero-Enteric Anastomosis for Crohn's Disease: A Case-Control Study.
    J Crohns Colitis. 2025 Sep 5:jjaf163. doi: 10.1093.
    

    >> Share

    
    
17. GISBERT JP, Chaparro M
    Combination therapy with biologics and/or small molecules in inflammatory bowel disease: a comprehensive review.
    J Crohns Colitis. 2025 Sep 3:jjaf161. doi: 10.1093.
    

    >> Share

    
    
18. PRUIJT MJ, Neefjes-Borst EA, De Voogd FAE, Lange MM, et al
    Submucosal hyper-echogenicity on intestinal ultrasound is associated with fat deposition and predicts treatment non-response in patients with ulcerative colitis.
    J Crohns Colitis. 2025 Sep 1:jjaf158. doi: 10.1093.
    

    >> Share

    
    

    
    J Gastroenterol

19. TSUTSUI A, Murakami Y, Nishiwaki Y, Asakura K, et al
    Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn's disease in Japan in 2023.
    J Gastroenterol. 2025 Sep 2. doi: 10.1007/s00535-025-02295.
    

    >> Share

    
    

    
    PLoS One

20. MISAGHIAN S, Jafri MS
    Transcriptional profiling identification of inflammatory signaling pathways in ulcerative colitis.
    PLoS One. 2025;20:e0330332.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share